Ionis Pharmaceuticals Reports Q1 Adjusted Net Loss Of $(112)M Vs. $(97)M A Year Ago
Portfolio Pulse from Benzinga Newsdesk
Ionis Pharmaceuticals reported a Q1 adjusted net loss of $(112)M, compared to $(97)M a year ago, indicating a widening loss.
May 07, 2024 | 11:05 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Ionis Pharmaceuticals reported a larger adjusted net loss in Q1 of $(112)M compared to $(97)M in the previous year.
The widening of the net loss for Ionis Pharmaceuticals in Q1 compared to the previous year suggests increased financial strain on the company. This is likely to negatively impact investor sentiment and could lead to a decrease in stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100